Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Answering the endocrine test questions.

C W Schmidt

    Environmental Health Perspectives
    |August 28, 1999
    PubMed
    Summary
    This summary is machine-generated.

    International efforts are underway to screen chemicals for endocrine disruption, a process that can increase risks of reproductive problems and cancer. Challenges exist in validating screening tests, with disagreements over methods and costs.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    What direction for u.s. Senate environmental policy?

    Environmental science & technology·2011
    Same author

    A closer look at chemical exposures in children.

    Environmental science & technology·2011
    Same author

    Amphibian deformities continue to puzzle researchers.

    Environmental science & technology·2011
    Same author

    Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53.

    British journal of cancer·2009
    Same author

    Small-molecule Bcl-2 inhibitors sensitise tumour cells to immune-mediated destruction.

    British journal of cancer·2007
    Same author

    Cross-presentation of a human malaria CTL epitope is conformation dependent.

    Molecular immunology·2006
    Same journal

    A New Start.

    Environmental health perspectives·2026
    Same journal

    Time-Varying Exposure to Element Mixtures and Children's Cognition at 5 Years of Age: Findings from the New Hampshire Birth Cohort Study.

    Environmental health perspectives·2026
    Same journal

    Effect of Household Air Pollution on the Gut Microbiome and Virome of Adult Women Living in Uganda.

    Environmental health perspectives·2026
    Same journal

    Comparison of Temperature-Mortality Associations across the Middle East Using Different Exposure Estimation Approaches.

    Environmental health perspectives·2026
    Same journal

    Workflow for Statistical Analysis of Environmental Mixtures.

    Environmental health perspectives·2026
    Same journal

    Effects of Extreme Heat Exposure on Heatstroke and Liver Injury in Mice: The Role of PPARα.

    Environmental health perspectives·2026
    See all related articles

    Area of Science:

    • Environmental Health
    • Toxicology
    • Endocrinology

    Background:

    • Growing evidence links chemical exposure to endocrine disruption, potentially causing reproductive issues and cancer.
    • The U.S. Environmental Protection Agency (EPA) identified 87,000 commercial chemicals requiring toxicity evaluation.
    • International efforts focus on screening chemicals for endocrine activity and health effects.

    Purpose of the Study:

    • To outline the challenges in validating screening and testing assays for endocrine-disrupting chemicals.
    • To address the need for a systematic approach to chemical safety evaluation.

    Main Methods:

    • The Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC) recommended a tiered system for chemical screening.
    • Focus on the validation of initial screening and testing assays.

    Related Experiment Videos

    Main Results:

    • Stakeholders are experiencing disagreements regarding the validation of specific tests for endocrine disruptors.
    • Key challenges include determining which tests to validate, the extent of validation required, and associated costs.

    Conclusions:

    • The validation of screening and testing assays is a critical but challenging first step in implementing a comprehensive endocrine disruptor evaluation system.
    • Resolving stakeholder disagreements is essential for the successful and cost-effective screening of chemicals for endocrine-disrupting potential.